Hagit Bar

Summary

Publications

  1. pmc Killing cancer cells by targeted drug-carrying phage nanomedicines
    Hagit Bar
    Department of Molecular Microbiology and Biotechnology, The George S, Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel
    BMC Biotechnol 8:37. 2008
  2. pmc Targeted drug-carrying bacteriophages as antibacterial nanomedicines
    Iftach Yacoby
    Green Building Room 202, Department of Molecular Microbiology and Biotechnology, Tel Aviv University, Ramat Aviv 69978, Israel
    Antimicrob Agents Chemother 51:2156-63. 2007
  3. pmc Targeting antibacterial agents by using drug-carrying filamentous bacteriophages
    Iftach Yacoby
    Department of Molecular Microbiology and Biotechnology, The George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Israel
    Antimicrob Agents Chemother 50:2087-97. 2006
  4. ncbi request reprint Utilization of amylose-lipid complexes as molecular nanocapsules for conjugated linoleic Acid
    Inbal Lalush
    Department of Biotechnology and Food Engineering, Technion Israel Institute of Technology, Haifa 32000, Israel
    Biomacromolecules 6:121-30. 2005

Collaborators

Detail Information

Publications4

  1. pmc Killing cancer cells by targeted drug-carrying phage nanomedicines
    Hagit Bar
    Department of Molecular Microbiology and Biotechnology, The George S, Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel
    BMC Biotechnol 8:37. 2008
    ..This shortcoming may be overcome by targeted drug-carrying platforms that ferry the drug to the tumor site while limiting exposure to non-target tissues and organs...
  2. pmc Targeted drug-carrying bacteriophages as antibacterial nanomedicines
    Iftach Yacoby
    Green Building Room 202, Department of Molecular Microbiology and Biotechnology, Tel Aviv University, Ramat Aviv 69978, Israel
    Antimicrob Agents Chemother 51:2156-63. 2007
    ..We demonstrate complete growth inhibition toward the pathogens Staphylococcus aureus, Streptococcus pyogenes, and Escherichia coli with an improvement in potency by a factor of approximately 20,000 compared to the free drug...
  3. pmc Targeting antibacterial agents by using drug-carrying filamentous bacteriophages
    Iftach Yacoby
    Department of Molecular Microbiology and Biotechnology, The George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Israel
    Antimicrob Agents Chemother 50:2087-97. 2006
    ..Reintroduction of such drugs into the arsenal of useful tools may help to combat emerging bacterial antibiotic resistance...
  4. ncbi request reprint Utilization of amylose-lipid complexes as molecular nanocapsules for conjugated linoleic Acid
    Inbal Lalush
    Department of Biotechnology and Food Engineering, Technion Israel Institute of Technology, Haifa 32000, Israel
    Biomacromolecules 6:121-30. 2005
    ..Only moderate release was detected following hydrolysis by amyloglucosidase and beta-amylase. It is therefore suggested that amylose-CLA complexes can serve as molecular nanocapsules for protection and delivery of CLA...